Furthermore, a recent, detailed study of pancreatic NEN after expert pathologist assessment to separate G3 NETs from NECs also did not show a Ki67 index > 55% to be predictive of the response to platinum-based therapy [6] Further studies are required to better characterise this association in EP-PD-NEC [12]. The gene discussed is MKI67; the disease is neuroendocrine carcinoma.